- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 7, 2026 | 150.34M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 148M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 136.35M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 2.32M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 975.73K sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$5M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$1.05M |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $13.64M |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $11.56M |
| Long Term Debt | Q3 2026 · Mar 31, 2025 | $259.06K |
| Short Term Debt | Q3 2026 · Mar 31, 2026 | $1.32M |
| Short Term Debt | Q3 2026 · Jun 30, 2025 | $4.51M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $16.71M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $7.53M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $22.26M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $21.68M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $6.86M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$6.8M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$13.96M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$23.2M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | −$23.16M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$38.11M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $30.82M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $41M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $51.66M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $67.69M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $46.92M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $34.93M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $73.92M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $60.89M |
| Total Assets restated | Q3 2026 · Mar 31, 2025 | $60.89M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.05 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$1.25 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.52 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.04 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$1.25 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $7.61 |
| Net Income | Q3 2026 · Mar 31, 2026 | −$1.93M |
| Net Income | Q3 2026 · Mar 31, 2026 | $4.41M |
| Net Income | Q3 2026 · Dec 31, 2025 | $6.78M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$440.29K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$2.9M |
| Net Income | Q3 2026 · Mar 31, 2025 | $7.43M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$419.69K |
| Net Income | Q3 2026 · Sep 30, 2024 | $10.75M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$2.93M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$6.27M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.07M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$3.16M |
| Revenue | Q3 2026 · Mar 31, 2026 | $4.2M |
| Revenue | Q3 2026 · Mar 31, 2026 | $13.51M |
| Revenue | Q3 2026 · Mar 31, 2025 | $2.54M |
| Revenue | Q3 2026 · Mar 31, 2025 | $8.09M |
| Stock Repurchased | Q3 2026 · Oct 8, 2025 | $334.06K |